Literature DB >> 14984500

Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults.

Nashaat S Hamza1, Michelle Lisgaris, Gopala Yadavalli, Laura Nadeau, Robert Fox, Pingfu Fu, Hillard M Lazarus, Omer N Koc, Robert A Salata, Mary J Laughlin.   

Abstract

Sources for allogeneic stem cells for patients with haematological disorders lacking a histocompatible sibling donor include matched unrelated donor (MUD) and umbilical cord blood (UCB). A total of 51 patients with haematological disorders, treated with myeloablation and transplantation with either unrelated human leucocyte antigen (HLA) partially matched UCB (28 patients) or HLA-matched MUD grafts (23 patients) during 1997-2003, were evaluated for life-threatening infections, haematological reconstitution, graft versus host disease, relapse and event-free survival (EFS). The median duration of neutropenia after transplantation was longer (29 d vs. 14 d) in the UCB group. The probability of donor-derived neutrophil engraftment by day 42 was 0.86 [95% confidence interval (CI) 0.71-1.0] in UCB recipients versus 0.96 (95% CI 0.87-1.0) in MUD recipients surviving >28 d. Overall infection rates were higher in UCB recipients, particularly at the early time points (before day +50) after transplantation. Graft failure occurred in five UCB recipients and two MUD recipients and was associated with the occurrence of bacteraemia during neutropenia. The EFS at 3-year follow-up was 0.25 in UCB and 0.35 in MUD recipients. UCB transplantation in adults is associated with delayed neutrophil and lymphocyte recovery compared with MUD grafting, and higher rates of bacteraemia at early time points after transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984500     DOI: 10.1046/j.1365-2141.2003.04792.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  27 in total

Review 1.  Umbilical cord blood immunology: relevance to stem cell transplantation.

Authors:  Syh-Jae Lin; Dah-Chin Yan; Yen-Chang Lee; Hsiu-Shan Hsiao; Pei-Tzu Lee; Yu-Wen Liang; Ming-Ling Kuo
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

2.  Late infectious complications after cord blood stem cell transplantation.

Authors:  N G Almyroudis; J Fabian; T Hahn; B H Segal; M Wetzler; P L McCarthy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-12       Impact factor: 3.267

3.  Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation.

Authors:  Victor E Mulanovich; Ying Jiang; Marcos de Lima; Elizabeth J Shpall; Richard E Champlin; Stefan O Ciurea
Journal:  Am J Blood Res       Date:  2011-06-07

4.  Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.

Authors:  Sarah Anand; Samantha Thomas; Kelly Corbet; Cristina Gasparetto; Gwynn D Long; Richard Lopez; Ashley K Morris; David A Rizzieri; Keith M Sullivan; Anthony D Sung; Stefanie Sarantopoulos; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-17       Impact factor: 5.742

5.  Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts.

Authors:  K Mizrahi; S Ash; T Peled; I Yaniv; J Stein; N Askenasy
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

6.  microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells.

Authors:  R Patrick Weitzel; Mathew L Lesniewski; Peter Haviernik; Suzanne Kadereit; Patrick Leahy; Nicholas J Greco; Mary J Laughlin
Journal:  Blood       Date:  2009-03-13       Impact factor: 22.113

7.  Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.

Authors:  Priya Kumar; Todd E Defor; Claudio Brunstein; Juliet N Barker; John E Wagner; Daniel J Weisdorf; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2008-12       Impact factor: 5.742

8.  Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: experience of a single institution in Japan.

Authors:  Akira Tomonari; Satoshi Takahashi; Jun Ooi; Nobuhiro Tsukada; Takaaki Konuma; Takeshi Kobayashi; Aki Sato; Kashiya Takasugi; Tohru Iseki; Arinobu Tojo; Shigetaka Asano
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

9.  Comparison of two methods used for monitoring low-copy cytomegalovirus infection in a patient with chronic myeloid leukemia after unrelated umbilical cord blood transplantation.

Authors:  Tomasz Dzieciatkowski; Maciej Przybylski; Agnieszka Tomaszewska; Małgorzata Rokicka; Mirosław Łuczak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-06-08       Impact factor: 4.291

10.  Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cells.

Authors:  Giuseppina Bonanno; Andrea Mariotti; Annabella Procoli; Maria Corallo; Giovanni Scambia; Luca Pierelli; Sergio Rutella
Journal:  BMC Immunol       Date:  2009-08-27       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.